Mass Spectrometry Market

Executive Summary

Mass Spectrometry Market was valued at US $16.35 billion in 2021 and is projected to grow at 7.57% CAGR over the forecast period to reach US $25.33 billion by 2027. Mass Spectrometry Market represented US $2.22 billion opportunity over 2019-2021 and estimated to create US $8.98 billion opportunity in 2027 over 2021.

Mass Spectrometry from Consainsights analyses the Mass Spectrometry Market in the Life Sciences industry over the forecast period to 2027.

Mass Spectrometry research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Mass Spectrometry segmentation includes Technology, Application, End-user, Region and Geography.

Based on the Technology, the Mass Spectrometry analysis covers Hybrid Mass Spectrometry, Single Mass Spectrometry, Other Mass Spectrometry Technologies.

In Technology segment, Hybrid Mass Spectrometry segment has highest cagr growth of 6.70%.

Based on the Application, the Mass Spectrometry analysis covers Life Science Research, Drug Discovery, Environmental Testing, Food Testing, Applied Industries, Clinical Diagnostics, Other Applications.

In Application segment, Life Science Research segment has highest cagr growth of 6.70%.

Based on the End-user, the Mass Spectrometry analysis covers Pharmaceutical Industry, Biotechnology Industry, Research & Academic Institutes, Environmental Testing Industry, Food & Beverage Testing Industry, Petrochemical Industry, Other End-users.

In End-user segment, Pharmaceutical Industry segment has highest cagr growth of 6.70%.

Based on the Region, the Mass Spectrometry analysis covers North America, Europe, Asia-Pacific, Latin America, Middle East & Africa.

In Region segment, North America segment has highest cagr growth of 6.70%.

Based on the region, the Mass Spectrometry analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.

Key companies operating in the market include Thermo Fisher Scientific, Sciex, Agilent Technologies, Waters Corporation, Shimadzu Corporation, Bruker Corporation, Perkinelmer, Jeol, Flir Systems, Mks Instruments, Analytik Jena, Hiden Analytical, Dani Instruments, Rigaku, Leco, Kore Technology, Extrel CMS, Masstech, Ametek Process Instruments, Advion and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Market Overview

Definition & Scope

The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.

The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.

The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.

Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.

Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.

As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.

Currency, Year & Forecast

The currency used in this report is USD, with the market size indicated in terms of USD million/billion.

For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.

For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.

Technology

Introduction

In 2021, Hybrid Mass Spectrometry segment has the highest revenue of US $11.65 billion and is expected to grow at CAGR of 6.70% by 2027 Hybrid Mass Spectrometry segment has highest cagr growth of 6.70%.

Hybrid Mass Spectrometry

Hybrid Mass Spectrometry segment was valued at US $10.07 billion in 2019 and is projected to grow at 6.70% CAGR over the forecast period to reach US $18.05 billion by 2027. Hybrid Mass Spectrometry segment represented US $1.58 billion opportunity over 2019-2021 and estimated to create US $6.40 billion opportunity in 2027 over 2021.

Single Mass Spectrometry

Single Mass Spectrometry segment was valued at US $3.30 billion in 2019 and is projected to grow at 6.70% CAGR over the forecast period to reach US $5.91 billion by 2027. Single Mass Spectrometry segment represented US $0.52 billion opportunity over 2019-2021 and estimated to create US $2.10 billion opportunity in 2027 over 2021.

Other Mass Spectrometry Technologies

Other Mass Spectrometry Technologies segment was valued at US $0.77 billion in 2019 and is projected to grow at 6.70% CAGR over the forecast period to reach US $1.37 billion by 2027. Other Mass Spectrometry Technologies segment represented US $0.12 billion opportunity over 2019-2021 and estimated to create US $0.49 billion opportunity in 2027 over 2021.

Application

Introduction

In 2021, Life Science Research segment has the highest revenue of US $6.21 billion and is expected to grow at CAGR of 6.70% by 2027 Life Science Research segment has highest cagr growth of 6.70%.

Life Science Research

Life Science Research segment was valued at US $5.37 billion in 2019 and is projected to grow at 6.70% CAGR over the forecast period to reach US $9.62 billion by 2027. Life Science Research segment represented US $0.84 billion opportunity over 2019-2021 and estimated to create US $3.41 billion opportunity in 2027 over 2021.

Drug Discovery

Drug Discovery segment was valued at US $3.59 billion in 2019 and is projected to grow at 6.70% CAGR over the forecast period to reach US $6.43 billion by 2027. Drug Discovery segment represented US $0.56 billion opportunity over 2019-2021 and estimated to create US $2.28 billion opportunity in 2027 over 2021.

Environmental Testing

Environmental Testing segment was valued at US $2.31 billion in 2019 and is projected to grow at 6.70% CAGR over the forecast period to reach US $4.14 billion by 2027. Environmental Testing segment represented US $0.36 billion opportunity over 2019-2021 and estimated to create US $1.47 billion opportunity in 2027 over 2021.

Food Testing

Food Testing segment was valued at US $1.56 billion in 2019 and is projected to grow at 6.70% CAGR over the forecast period to reach US $2.80 billion by 2027. Food Testing segment represented US $0.25 billion opportunity over 2019-2021 and estimated to create US $0.99 billion opportunity in 2027 over 2021.

Applied Industries

Applied Industries segment was valued at US $0.62 billion in 2019 and is projected to grow at 6.70% CAGR over the forecast period to reach US $1.12 billion by 2027. Applied Industries segment represented US $0.10 billion opportunity over 2019-2021 and estimated to create US $0.40 billion opportunity in 2027 over 2021.

Clinical Diagnostics

Clinical Diagnostics segment was valued at US $0.36 billion in 2019 and is projected to grow at 6.70% CAGR over the forecast period to reach US $0.64 billion by 2027. Clinical Diagnostics segment represented US $0.06 billion opportunity over 2019-2021 and estimated to create US $0.23 billion opportunity in 2027 over 2021.

Other Applications

Other Applications segment was valued at US $0.33 billion in 2019 and is projected to grow at 6.70% CAGR over the forecast period to reach US $0.59 billion by 2027. Other Applications segment represented US $0.05 billion opportunity over 2019-2021 and estimated to create US $0.21 billion opportunity in 2027 over 2021.

End-user

Introduction

In 2021, Pharmaceutical Industry segment has the highest revenue of US $6.87 billion and is expected to grow at CAGR of 6.70% by 2027 Pharmaceutical Industry segment has highest cagr growth of 6.70%.

Pharmaceutical Industry

Pharmaceutical Industry segment was valued at US $5.94 billion in 2019 and is projected to grow at 6.70% CAGR over the forecast period to reach US $10.64 billion by 2027. Pharmaceutical Industry segment represented US $0.93 billion opportunity over 2019-2021 and estimated to create US $3.77 billion opportunity in 2027 over 2021.

Biotechnology Industry

Biotechnology Industry segment was valued at US $3.53 billion in 2019 and is projected to grow at 6.70% CAGR over the forecast period to reach US $6.33 billion by 2027. Biotechnology Industry segment represented US $0.56 billion opportunity over 2019-2021 and estimated to create US $2.25 billion opportunity in 2027 over 2021.

Research & Academic Institutes

Research & Academic Institutes segment was valued at US $2.19 billion in 2019 and is projected to grow at 6.70% CAGR over the forecast period to reach US $3.92 billion by 2027. Research & Academic Institutes segment represented US $0.34 billion opportunity over 2019-2021 and estimated to create US $1.39 billion opportunity in 2027 over 2021.

Environmental Testing Industry

Environmental Testing Industry segment was valued at US $1.29 billion in 2019 and is projected to grow at 6.70% CAGR over the forecast period to reach US $2.32 billion by 2027. Environmental Testing Industry segment represented US $0.20 billion opportunity over 2019-2021 and estimated to create US $0.82 billion opportunity in 2027 over 2021.

Food & Beverage Testing Industry

Food & Beverage Testing Industry segment was valued at US $0.59 billion in 2019 and is projected to grow at 6.70% CAGR over the forecast period to reach US $1.05 billion by 2027. Food & Beverage Testing Industry segment represented US $0.09 billion opportunity over 2019-2021 and estimated to create US $0.37 billion opportunity in 2027 over 2021.

Petrochemical Industry

Petrochemical Industry segment was valued at US $0.33 billion in 2019 and is projected to grow at 6.70% CAGR over the forecast period to reach US $0.58 billion by 2027. Petrochemical Industry segment represented US $0.05 billion opportunity over 2019-2021 and estimated to create US $0.21 billion opportunity in 2027 over 2021.

Other End-users

Other End-users segment was valued at US $0.27 billion in 2019 and is projected to grow at 6.70% CAGR over the forecast period to reach US $0.48 billion by 2027. Other End-users segment represented US $0.04 billion opportunity over 2019-2021 and estimated to create US $0.17 billion opportunity in 2027 over 2021.

Region

Introduction

In 2021, North America segment has the highest revenue of US $7.11 billion and is expected to grow at CAGR of 6.70% by 2027 North America segment has highest cagr growth of 6.70%.

North America

North America segment was valued at US $6.15 billion in 2019 and is projected to grow at 6.70% CAGR over the forecast period to reach US $11.02 billion by 2027. North America segment represented US $0.97 billion opportunity over 2019-2021 and estimated to create US $3.91 billion opportunity in 2027 over 2021.

Europe

Europe segment was valued at US $3.95 billion in 2019 and is projected to grow at 6.70% CAGR over the forecast period to reach US $7.09 billion by 2027. Europe segment represented US $0.62 billion opportunity over 2019-2021 and estimated to create US $2.51 billion opportunity in 2027 over 2021.

Asia-Pacific

Asia-Pacific segment was valued at US $2.04 billion in 2019 and is projected to grow at 6.70% CAGR over the forecast period to reach US $3.66 billion by 2027. Asia-Pacific segment represented US $0.32 billion opportunity over 2019-2021 and estimated to create US $1.30 billion opportunity in 2027 over 2021.

Latin America

Latin America segment was valued at US $1.56 billion in 2019 and is projected to grow at 6.70% CAGR over the forecast period to reach US $2.79 billion by 2027. Latin America segment represented US $0.24 billion opportunity over 2019-2021 and estimated to create US $0.99 billion opportunity in 2027 over 2021.

Middle East & Africa

Middle East & Africa segment was valued at US $0.43 billion in 2019 and is projected to grow at 6.70% CAGR over the forecast period to reach US $0.77 billion by 2027. Middle East & Africa segment represented US $0.07 billion opportunity over 2019-2021 and estimated to create US $0.27 billion opportunity in 2027 over 2021.